Immunization Status HCPCS Code range G2154-G2165

The HCPCS codes range Immunization Status G2154-G2165 is a standardized code set necessary for Medicare and other health insurance providers to provide healthcare claims.

Introducing Codify by AAPC! Designed by Coders. Customized by You.

Everything you loved, just easier, more customizable, and enhanced with new features. Available in a variety of subscription levels to suit your needs.

See What's New Buy Now

HCPCS Code Range G2154-G2165

G2154-G2165 Immunization Status
Patient received at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period
Patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)
Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)
Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period
Patient had prior pneumococcal vaccine adverse reaction any time during or before the measurement period
Patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement period
Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period
Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period
Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period
Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
Showing 1 to 10 of 12 results
1 2 >